Baotou Dongbao Bio-Tech Co Ltd (300239) — Strategic Asset Allocation Index
Baotou Dongbao Bio-Tech Co Ltd (300239) has a Strategic Asset Allocation Index of 59.1% as of June 2023. Strategic assets (PP&E of CN¥1.07 Billion plus long-term investments of CN¥-) total CN¥1.07 Billion, measured against net assets of CN¥1.81 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Baotou Dongbao Bio-Tech Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Baotou Dongbao Bio-Tech Co Ltd Strategic Asset Allocation Index (2008–2022)
This chart shows how Baotou Dongbao Bio-Tech Co Ltd's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of June 2023, the index stands at 59.1%, representing strategic assets of CN¥1.07 Billion against net assets of CN¥1.81 Billion CNY. See Baotou Dongbao Bio-Tech Co Ltd (300239) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Baotou Dongbao Bio-Tech Co Ltd (2008–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Baotou Dongbao Bio-Tech Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 58.0% | CN¥1.02 Billion | CN¥1.02 Billion | CN¥- | CN¥1.76 Billion | ▼ -2.3 pp |
| 2021 | 60.3% | CN¥966.90 Million | CN¥966.90 Million | CN¥- | CN¥1.60 Billion | ▼ -21.1 pp |
| 2020 | 81.4% | CN¥812.04 Million | CN¥812.04 Million | CN¥- | CN¥998.18 Million | ▲ +6.5 pp |
| 2019 | 74.9% | CN¥742.71 Million | CN¥742.71 Million | CN¥- | CN¥991.86 Million | ▼ -11.1 pp |
| 2018 | 86.0% | CN¥645.47 Million | CN¥636.73 Million | CN¥8.74 Million | CN¥750.88 Million | ▲ +6.4 pp |
| 2017 | 79.6% | CN¥580.62 Million | CN¥574.81 Million | CN¥5.80 Million | CN¥729.75 Million | ▲ +20.4 pp |
| 2016 | 59.2% | CN¥425.56 Million | CN¥421.47 Million | CN¥4.09 Million | CN¥718.86 Million | ▲ +26.2 pp |
| 2015 | 33.0% | CN¥233.13 Million | CN¥233.13 Million | CN¥- | CN¥706.55 Million | ▼ -28.3 pp |
| 2014 | 61.3% | CN¥208.63 Million | CN¥208.63 Million | CN¥- | CN¥340.56 Million | ▼ -1.0 pp |
| 2013 | 62.3% | CN¥218.88 Million | CN¥218.88 Million | CN¥- | CN¥351.47 Million | ▼ -4.1 pp |
| 2012 | 66.4% | CN¥215.03 Million | CN¥215.03 Million | CN¥- | CN¥324.03 Million | ▲ +9.2 pp |
| 2011 | 57.2% | CN¥169.26 Million | CN¥169.26 Million | CN¥- | CN¥295.99 Million | ▼ -43.9 pp |
| 2010 | 101.1% | CN¥123.80 Million | CN¥123.80 Million | CN¥- | CN¥122.44 Million | ▼ -18.2 pp |
| 2009 | 119.3% | CN¥120.11 Million | CN¥120.11 Million | CN¥- | CN¥100.65 Million | ▲ +7.5 pp |
| 2008 | 111.8% | CN¥109.44 Million | CN¥109.44 Million | CN¥- | CN¥97.87 Million | — |